Overview and Scope
Autotransfusion devices refer to tools used to collect and reinfuse a patient’s blood during a medical procedure, instead of using donated blood. This process is also known as autologous blood transfusion and can help reduce the need for allogenic (separate-donor) blood transfusions. Autotransfusion devices are commonly used in trauma patients in the emergency department and during surgeries.
Sizing and Forecast
The autotransfusion devices market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, efforts to reduce blood transfusion costs.
The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, miniaturization of devices.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report
Segmentation & Regional Insights
The autotransfusion devices market covered in this report is segmented –
1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users
North America was the largest region in the autotransfusion devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10275&type=smp
Major Driver Impacting Market Growth
Increasing prevalence of cardiovascular diseases is expected to propel the growth of the autotransfusion device market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels. Autotransfusion devices contribute to the trend of minimizing the use of allogeneic blood transfusions. Allogeneic transfusions involve donated blood from external sources, and autotransfusion allows for the reinfusion of the patient’s own blood, reducing the risk of transfusion reactions and complications associated with donor blood. For instance, according to the Heart Disease and Stroke Statistics-2022 Update report by American Heart Association, a US-based non-profit organization, cardiovascular diseases (CVDs) remain the leading cause of death globally, taking an estimated 17.9 million lives each year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the autotransfusion device market.
Key Industry Players
Major companies operating in the autotransfusion devices market report are Becton Dickinson And Company, Medtronic PLC, LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., Miltenyi Biotec, B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Advancis Surgical, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, ProCell Surgical Inc., Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation, Advantech Wireless Technologies Inc.
The autotransfusion devices market report table of contents includes:
1. Executive Summary
2. Autotransfusion Devices Market Characteristics
3. Autotransfusion Devices Market Trends And Strategies
4. Autotransfusion Devices Market – Macro Economic Scenario
5. Global Autotransfusion Devices Market Size and Growth
.
.
.
31. Global Autotransfusion Devices Market Competitive Benchmarking
32. Global Autotransfusion Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Autotransfusion Devices Market
34. Autotransfusion Devices Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
